Search

Search results

157 results found

Proceedings of the First Neuropalliative Care Research Summit (NeuroCARES).

Publication: Journal Article

Creutzfeldt, C J, J Bogetz, C Candrian, K L Colborn, R C Crooms, C R Fehnel, J E Fleisher, et al. 2025. “Proceedings of the First Neuropalliative Care Research Summit (NeuroCARES).”. Journal of Pain and Symptom Management.

View our Presentations & Projects

Presentation: August 27, 2025

Extending and Terminating Current Research Student/Postdoctoral Fellow Roles

Page

Once a student or postdoc research fellow reaches their official end date, supervisors can either choose to extend the experience, or begin the offboarding and termination steps. The steps below outline the process for extending current research student or postdoctoral research fellows current work...

Fernando Moreno

Person: Clinical Research Coordinator, FIRST Program, Department of Surgery, Beth Israel Deaconess Medical Center

Soumya Nagesh, MS

Person: Bioinformatician

Appropriate Therapeutic Drug Monitoring of Biologic Agents for Patients With Inflammatory Bowel Diseases.

Publication: Journal Article

Papamichael, Konstantinos, Adam S Cheifetz, Gil Y Melmed, Peter M Irving, Niels Vande Casteele, Patricia L Kozuch, Laura E Raffals, et al. 2019. “Appropriate Therapeutic Drug Monitoring of Biologic Agents for Patients With Inflammatory Bowel Diseases.”. Clinical Gastroenterology and Hepatology : The Official Clinical Practice Journal of the American Gastroenterological Association 17 (9): 1655-1668.e3.

Higher Postinduction Infliximab Concentrations Are Associated With Improved Clinical Outcomes in Fistulizing Crohn's Disease: An ACCENT-II Post Hoc Analysis.

Publication: Journal Article

Papamichael, Konstantinos, Niels Vande Casteele, Jenny Jeyarajah, Vipul Jairath, Mark T Osterman, and Adam S Cheifetz. 2021. “Higher Postinduction Infliximab Concentrations Are Associated With Improved Clinical Outcomes in Fistulizing Crohn’s Disease: An ACCENT-II Post Hoc Analysis.”. The American Journal of Gastroenterology 116 (5): 1007-14.

Proactive infliximab optimisation using a pharmacokinetic dashboard versus standard of care in patients with Crohn's disease: study protocol for a randomised, controlled, multicentre, open-label study (the OPTIMIZE trial).

Publication: Journal Article

Papamichael, Konstantinos, Vipul Jairath, Guangyong Zou, Benjamin Cohen, Timothy Ritter, Bruce Sands, Corey Siegel, et al. 2022. “Proactive Infliximab Optimisation Using a Pharmacokinetic Dashboard versus Standard of Care in Patients With Crohn’s Disease: Study Protocol for a Randomised, Controlled, Multicentre, Open-Label Study (the OPTIMIZE Trial).”. BMJ Open 12 (4): e057656.

News and Archives

Page

Davide De Marco, M.D.

Person: Inflammatory Bowel Disease Fellow

Born and raised in Montreal, Davide attended McGill Medical School where he graduated in 2020. He then went on to complete internal medicine and gastroenterology and hepatology residency at McGill in 2025. He is currently enrolled in the Beth Israel Deaconess Medical Center Advanced Inflammatory...